Hemorrhagic bladder is an adverse effect associated with the use of cyclophosphamide in patients with lupus nephritis can be reduced by administering which of the following?
A. Folic acid
B. Desferoxamine
C. Febuxostat
D. Mesna
E. Cobalamin